For participants in clinical trials, the answer is a hard no. The Trump administration's decision to end funding for the U.S.

Harsha Vardhan Reddy Yeddula's research highlights the transformative power of AI in reshaping clinical trials, paving the ...

February, I decided to leave a job I had loved as a science writer at the NIH, in large part because it seemed as if I would ...

Ron Lanton, Partner, Lanton Law, discusses how stakeholders must navigate funding future clinical research amid NIH budget ...

Billionaire Entrepreneur Glen Taylor, the Company's Largest Shareholder, Continues to Invest Significant Capital into the Company Furthering Its ...

Clinical trials offer hope and access to potentially life-saving treatments, especially for the Black community.

Thursday's session focused on the "Future of Medicine" program through Care Access. This health screening initiative provides ...

This is the third indication under clinical development for soquelitinib, which is also in a registrational Phase 3 trial for peripheral T cell lymphoma (PTCL) and a Phase 1 trial for atopic ...

Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research SessionMarlborough, Massachusetts--(Newsfile ...

Listing multiple clinical trials in various stages may indicate ... (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...